World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00311051
Date of registration: 01/04/2006
Primary sponsor: Research Center Borstel
Public title: Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Asthma Sensitive to House Dust Mite
Scientific title: A Randomized Double-blind and Placebo-controlled Study to the Influence of Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Patients With Mild to Moderate Atopic Asthma (House Dust Mite)
Date of first enrolment: April 2005
Target sample size: 0
Recruitment status: Withdrawn
URL:  http://clinicaltrials.gov/show/NCT00311051
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment  
Countries of recruitment
Germany
Contacts
Name:   Peter Zabel, Prof.
Address: 
Telephone:
Email:
Affiliation:  Research Center Borstel
Key inclusion & exclusion criteria

Inclusion Criteria:

- Atopic (house dust mite) asthma

- Severity GINA one and two

Exclusion Criteria:

- No reaction in specific bronchial provocation test

- Other kind of clinical relevant atopic reaction



Age minimum: 18 Years
Age maximum: 65 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Asthma
Intervention(s)
Drug: montelukast
Drug: ramatroban
Primary Outcome(s)
Allergen concentration for specific bronchoprovocation
Lung function by spirometry
Secondary Outcome(s)
Blood level of thromboxane and leukotriene metabolite
Secondary ID(s)
4022229
Bundesinstitut (BfArM)
RAMONA-4022229
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history